Celon Pharma S.A. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported revenue was PLN 199.11 million compared to PLN 159.99 million a year ago. Net loss was PLN 11.61 million compared to PLN 0.917 million a year ago. Basic loss per share from continuing operations was PLN 0.25 compared to PLN 0.02 a year ago. Diluted loss per share from continuing operations was PLN 0.25 compared to PLN 0.02 a year ago.